Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Carrier Global Corporation in connection with a sale of 9.25 million B shares in Beijer Ref AB (publ)
Mandate

Vinge has advised Carrier Global Corporation in connection with a sale of 9.25 million B shares in Beijer Ref AB (publ)

September 23, 2020 Capital Markets and Public M&A

Vinge has advised Carrier Global Corporation in connection with a sale of 9.25 million B shares in Beijer Ref AB (publ) through an accelerated equity offering, with a total transaction value of approximately SEK 2.7 billion

Carrier Global Corporation (“Carrier”) is a leading global provider of heating, ventilating and air conditioning (HVAC), refrigeration, fire, security and building automation technologies, and is listed on the New York Stock Exchange.

Beijer Ref AB (publ) (“Beijer Ref”) provides commercial and industrial refrigeration as well as heating and air conditioning products and is listed on Nasdaq Stockholm.

The sold shares equal approximately 7.9 percent of the outstanding B shares in Beijer Ref. Following the transaction, Carrier continues to hold approximately 30 percent of the Beijer Ref B share capital, approximately 22 percent of the Beijer Ref A share capital and approximately 26 percent of the Beijer Ref total votes.

Vinge’s team consisted of Charlotte Levin, Linnéa Sellström, Anders Sundin Lundberg and Clara Sohlberg.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026